Page last updated: 2024-08-17

bretylium tosylate and Diabetes Mellitus, Type 2

bretylium tosylate has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basu, A; Charkoudian, N; Fealey, RD; Roberts, SK; Sandroni, P; Sletten, D; Wick, DE	1

Other Studies

1 other study(ies) available for bretylium tosylate and Diabetes Mellitus, Type 2

Article	Year
Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus. Journal of applied physiology (Bethesda, Md. : 1985), 2006, Volume: 100, Issue:2 Topics: Adrenergic Antagonists; Body Temperature; Body Temperature Regulation; Bretylium Tosylate; Diabetes Mellitus, Type 2; Hot Temperature; Humans; Laser-Doppler Flowmetry; Middle Aged; Regional Blood Flow; Skin; Sympathetic Nervous System; Vasodilation	2006

Article

Year

Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus.

Journal of applied physiology (Bethesda, Md. : 1985), 2006, Volume: 100, Issue:2

Topics: Adrenergic Antagonists; Body Temperature; Body Temperature Regulation; Bretylium Tosylate; Diabetes Mellitus, Type 2; Hot Temperature; Humans; Laser-Doppler Flowmetry; Middle Aged; Regional Blood Flow; Skin; Sympathetic Nervous System; Vasodilation

2006